The development of efficient systems for in vivo gene transfer to the central nervous system (CNS) may provide a useful therapeutic strategy for the alleviation of several neurological disorders. In this study, we evaluated the feasibility of nonviral gene therapy to the CNS mediated by cationic liposomes. We present evidence of the successful delivery and expression of both a reporter and a therapeutic gene in the rodent brain, as evaluated by immunohistochemical assays. Our results indicate that transferrin-associated cationic liposome/DNA complexes (Tf-lipoplexes) allow a significant enhancement of transfection activity as compared to plain complexes, and that 8/1 (+/À) Tf-lipoplexes constitute the best formulation to mediate in vivo gene transfer. We demonstrated that Tf-lipoplex-mediated nerve growth factor transgene expression attenuates the morphological damages of the kainic acid-induced lesion as assessed by 2,3,5-triphenyltetrazolium chloride (TTC) vital staining. These findings suggest the usefulness of these lipid-based vectors in mediating the delivery of therapeutic genes to the CNS.
Introduction
Owing to the presence of the blood-brain barrier (BBB), the central nervous system (CNS) is not easily accessible to systemically delivered macromolecules with therapeutic activity such as growth factors, cytokines or enzymes. 1, 2 Therefore, the expression of exogenously administered genes in the brain has been proposed for a wide variety of inherited and acquired diseases of the CNS, 3, 4 for which classical pharmacotherapy is unavailable or not easily applicable. Gene transfer into the CNS has been investigated for the purpose of protection against neuronal insults and degeneration. Promising candidates for gene therapy are the neurotrophic factors [5] [6] [7] [8] and the antioxidative agents, which are of major interest for neuroprotection in pathological conditions involving free radicals (amyotrophic lateral sclerosis, Parkinson's, Alzheimer's and Huntington's diseases, cerebral ischaemia and others). 9 The choice of an appropriate vector system for transferring the desired gene into the affected brain area is an important issue for developing a safe and efficient gene therapy approach for the CNS. During the past few years, much of the gene therapy research has resulted in significant progress with regard to the development of approaches for CNS gene transfer, and evaluation of their potential to treat neurological disorders. Among the different systems that have been developed for this purpose, viral vectors have been the most widely used. Transduction with adeno-associated viral vectors [10] [11] [12] or lentiviral vectors [13] [14] [15] [16] has resulted in a reasonable extent of gene expression in the target regions of the CNS. 17, 18 Safety concerns associated with the use of viral vectors prompted investigators to evaluate the ability of nonviral vectors to mediate gene delivery to CNS. Among nonviral vectors, cationic liposomes have several attractive features for gene transfer to neuronal tissue, including simplicity and safety. 19, 20 It has been widely demonstrated that cationic liposomes can efficiently condense DNA and increase transfection efficiency both in vitro and in vivo. 21, 22 Lipoplexes have several attractive features as vectors for gene transfer: (1) they are nonimmunogenic and nontoxic at therapeutic doses; (2) they can transfect postmitotic, nondividing cells, including neurons; (3) they can be used to deliver multiple genes of any type of nucleic acids (linear or supercoiled); (4) they are relatively simple to prepare and can be administered into the body by several different routes; (5) the persisting extrachromosomal state of delivered plasmids reduces the possibility that transfected cells would undergo neoplastic transformation.
Lipoplexes have been used for in vivo gene transfer, but they aggregate extensively in biological fluids. 23 This colloidal instability results in selective gene expression in the lung, with little expression in peripheral tissues and no expression in the brain after intravenous (i.v.) administration. [23] [24] [25] Access to sites of action within the CNS can thus be considered a rate-limiting event in the clinical implementation of gene therapy for neurological disorders. Gene delivery systems, optimized for different routes of administration, are expected to result in efficient methods for maintaining therapeutic protein concentrations at target sites, while simultaneously limiting exposure to undesired sites. Owing to the failure of gene medicines to cross the BBB, invasive routes of administration, such as the intracerebral injection via craniotomy, have been explored. [26] [27] [28] Although lipoplex-mediated gene transfer into brain cells has already been reported in animal models, 19, 27, 29 the application of these systems has been limited because of their low transfection efficiency, especially in adult, postmitotic CNS cells. This problem may be primarily due to the presence of extremely low levels of endocytotic activity in such highly differentiated cells, resulting in reduced cellular uptake of genetic material.
Following the demonstration of the feasibility of transferrin-associated cationic liposome/DNA complexes (Tf-lipoplexes) to mediate efficient transfection of the rat brain, we evaluated their potential to deliver therapeutic genes. Gene therapy to the CNS was assessed in terms of the ability of nerve growth factor (NGF) to protect and promote regeneration of the excitotoxically injured rat striatum after intracerebral injection of kainic acid. Kainic acid is known to induce neuronal cell death in animal models, mimicking the injuries observed in neurodegenerative disorders such as Alzheimer's and Huntington's diseases, and in acute neurological lesions such as ischaemia, hypoglycaemia and trauma.
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Results
In vivo expression of a reporter gene Effect of associating transferrin to the complexes on transfection activity. We have previously demonstrated that Tf is highly effective in promoting lipoplexmediated transfection of a large variety of cells, [34] [35] [36] [37] including both cortical and hippocampal neuronal primary cultures. 38 Therefore, in this work, we evaluated whether this strategy would also result in an enhancement of in vivo rat brain transfection. For this purpose, lipoplexes prepared upon association of the pSIN-PGKnls-LacZ-WHV plasmid to 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP): cholesterol (Chol) liposomes, at the 8/1 lipid/DNA (+/À) charge ratio, in the presence or absence of Tf, were stereotactically injected in the striatum of Wistar rats. As shown in Figure 1a , association of Tf to the lipoplexes induced a three-fold increase of the extension of b-galactosidase (b-gal) expression in the rat brain striatum, when compared to plain lipoplexes. Figure 1b provides evidence that the stereotactic injection of plain lipoplexes resulted in the transfection of a small number of cells, restricted to the area surrounding the injection site (Figure 1b-ii) , whereas Tf-lipoplexes induced a b-gal transgene expression in a larger area that reached all the upper striatum (Figure 1b- iii, -iv, -v). No b-gal-stained cells were found in the striatum of the control animals (noninjected, or injected with Tf-lipoplexes containing pCMV-GFP) (Figure 1b-vi) . (Figure 2a) , the 8/1 (+/À) Tf-lipoplexes achieving a two-fold increase when compared to the efficiency of 16/1 (+/À) Tf-lipoplexes. Figure 2b also illustrates this finding, and as observed for the plain lipoplexes, the stereotactic injection of 16/1 (+/À) Tflipoplexes resulted in b-gal expression in an area restricted to the surroundings of the injection site, whereas the 8/1 (+/À) Tf-lipoplexes induced transgene expression in a larger area. It is possible that the increase in the net positive charge of the 8/1 and 16/1 (+/À) lipoplexes, as compared to the 2/1 or 4/1 (+/À) formulations, promotes electrostatic repulsions among the particles, thus preventing the formation of large aggregates, whose internalization would be hampered. The fact that the 16/1 (+/À) Tf-lipoplexes exhibit lower levels of transfection than the 8/1 (+/À) Tf-lipoplexes suggests that their high net positive charge may result in an extensive DNA condensation, which will prevent its efficient intracellular delivery.
Influence of plasmid promoter on transfection efficiency. It has been reported that the nature of the promoter can influence the levels and the duration of the transgene expression. 39 In particular, the cytomegalovirus (CMV) and the phosphoglycerate kinase (PGK) internal promoters are known to mediate high levels of gene expression, the PGK promoter also being associated to long-term expression. 40 Aiming at evaluating the possible significance of including different promoters in the expression plasmids to the in vivo transfection efficiency of lipoplexes, we performed transfection experiments employing a b-gal-encoding plasmid under the control of either the CMV or the PGK promoter. As illustrated in Figure 3a , the extension of b-gal expression was similar for both promoters, either for 24 or 48 h postinjection, and no significant differences were observed in the transfected areas (Figure 3b ). These results show that both the CMV and the PGK promoters lead to detectable levels of protein production in the striatum, thus representing potential candidates for expression of therapeutic genes in the brain. In this regard, previous studies with lentiviral vectors have evaluated both the LacZ expression associated with the PGK and the CMV promoters, b-galactosidase activity being much higher in striatal extracts from PGK-LacZ-injected animals as compared to CMV-LacZ animals, 41 when determined 1 week after injection. In contrast, in the present study, transduction of the rat brain with lipoplexes encoding LacZ associated to PGK or CMV promoters did not lead to significant differences of transgene expression levels. This may have resulted from the very short duration of gene expression mediated by lipoplexes (24 and 48 h) as compared to lentiviral vectors (1 week), thus avoiding loss of CMV activity.
In vivo NGF gene expression mediated by Tf-lipoplexes
In order to evaluate the in vivo expression of a potential therapeutic gene, Tf-lipoplexes prepared upon association of pCMV-NGF to Tf-containing DOTAP:Chol liposomes, at the 8/1 (+/À) lipid/DNA charge ratio, were injected stereotactically in the striatum of Wistar rats. Figure 4a shows the extension of protein expression, at 24 h, 48 h or 7 days after the injection of the lipoplexes, as assessed by immunohistochemical analysis. High extension of NGF is observed at 24 and 48 h, this being similar Tf-lipoplex-mediated gene transfer to the injured rat CNS M Teresa Girão da Cruz et al to that obtained for b-gal expression (compare with Figure 3 ). As illustrated in Figure 4b (i, ii), the labelling is specific for transgenic NGF and cannot be attributed to endogenous NGF, as no NGF immunoreactivity was observed either in the noninjected hemispheres or in the hemispheres injected with Tf-lipoplexes containing pCMV-GFP. At 7 days postinjection, the extension of NGF expression was significantly decreased (Figure 4a and 4b-iii), which confirms the transient nature of the Tf-lipoplex-mediated expression.
Effect of NGF expression on an in vivo model of excitotoxic lesion
Neurotoxicity mediated by glutamate is known to play an important role in several pathologies, such as cerebral ischaemia and neurodegenerative diseases. [42] [43] [44] Neuronal cell death is thought to be due, at least in part, to the massive influx of calcium induced by overactivation of glutamate receptors. 45, 46 Kainic acid, an agonist of AMPA receptors, is responsible for the initiation of an excitotoxic cascade, which results in the accumulation of excitatory amino acids, such as glutamate, and thus in the increase of intracellular calcium concentration. [47] [48] [49] Therefore, kainic acid has commonly been used to elicit a selective neurodegeneration, both in vitro 48 and in vivo. 50, 51 In this study, we induced an excitotoxic lesion by injecting kainic acid into the striatum of Wistar rats, and evaluated the potential therapeutic effect of NGF expression mediated by Tf-lipoplexes.
We first investigated whether NGF transgene delivery and expression were endangered by the presence of the kainic acid-induced lesion, by assessing NGF expression through immunohistochemical analysis. Figure 5 (a, b) shows that, in comparison to the nonlesioned NGF-transfected animals (experimental set [1] ), no significant differences were observed for the NGF expression independently of whether the kainic acid was infused stereotactically 24 h after the Tf-lipoplexes injection (experimental set [2] ) or immediately before the delivery of Tf-lipoplexes (experimental set [3] ). It should be noted that the lipoplexes and kainic acid injections took place 1 mm apart from each other, in an attempt to prevent lipoplex delivery close to the area where protein synthesis is more likely to be compromised, due to kainic acid-induced cell death.
The kainic acid-induced lesion was visualized by TTC staining assay (Figure 6 ), 24 h, 48 h or 7 days after a single kainic acid injection (0.05 mg), and the lesion volumes were determined as described in the 'Materials and methods' section. Figure 6a shows that 24 h after the kainic acid injection, it was already possible to distinguish a significant lesion in the striatum. At 48 h postinjection, an approximately three-fold increase in the lesion area was observed, this being still detectable 7 days later. Counterstaining with cresyl violet (Figure 6b) shows the presence of pyknotic cells and cellular vacuolization, which provides further evidence of the kainic acid-induced lesion. 
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To evaluate the potential therapeutic effect of NGF in the kainic acid-induced lesion, 0.05 mg of kainic acid were infused stereotactically either 24 h after the Tflipoplexes injection (experimental set [2] ), or immediately before the delivery of Tf-lipoplexes (experimental set [3] ). Experimental set [1] states for the control animals in which only kainic acid was injected. The lesion volumes were determined by TTC staining, 24 h, 48 h or 7 days postinjection. As illustrated in Figure 7 , a decrease in the lesion volume upon NGF transgene expression was observed, this being particularly significant (75% reduction, when compared to the control - Figure 7b ) 48 h after the lesion induction (time at which the highest volume of lesion is reached for controls).
Interestingly, no lesion could be detected by this method 7 days after the induction of the excitotoxic lesion, independently of whether the Tf-lipoplexes had been administered 24 h before or immediately after kainic acid injection. Moreover, no significant differences were observed between the lesion volumes obtained for the control animals [1] , and for those injected with Tflipoplexes containing the plasmid coding for b-gal either 24 h before [2*], or immediately after [3*], kainic acid injection, thus confirming that the observed therapeutic effect was due to NGF expression. Upon administration of Tf-lipoplexes in the absence of kainic acid, no lesion was detected by TTC or cresyl violet staining (data not shown), which indicates absence of in vivo toxicity induced by this liposome formulation. 
Discussion
Gene therapy to the CNS has been the target of a great number of studies aiming at finding a viable therapeutic strategy for the treatment of neurological disorders. This approach has already been used as a promising tool for brain protection and repair from neuronal insults and degeneration, not only in several animal models 3,4,12,29,52,53 but also in some clinical trials. 54, 55 The use of cationic liposomes as gene delivery systems has proven to be a less toxic and immunogenic approach as compared to the use of viral vectors, thus representing a viable alternative to the extensively employed viral vectors.
In the present work, we investigated the relevance of several parameters for in vivo lipoplex-mediated brain Tf-lipoplex-mediated gene transfer to the injured rat CNS M Teresa Girão da Cruz et al transfection. Considering the difficulties associated with gene transfer of postmitotic cells, such as neurons, and in an attempt to improve the efficiency of DOTAP:Chol liposomes, we evaluated whether the strategy previously developed in our laboratory, which includes the association of Tf to lipoplexes, would also lead to higher values of transfection in vivo. Our results clearly confirm the potential of this strategy to promote in vivo gene transfer to striatal cells. Tf-lipoplexes significantly enhanced the transgene expression, as compared to that mediated by plain lipoplexes. It should be emphasized that, in the developed formulations, Tf molecules are not covalently linked to the surface of lipoplexes. Instead, they are electrostatically associated to the cationic liposomes, and as a consequence, it is possible that not all the Tf-binding motifs are available at the surface of the lipoplexes to bind to the Tf receptors at the neuronal cell surface. However, this type of association seems to be sufficient to promote the endocytotic internalization of lipoplexes by a large number of cells. 37 In addition to the presence of Tf, the surface charge of the complexes and the amount of lipid employed in liposome preparation play an important role in determining lipoplex-cell interactions. When Tf-lipoplexes were prepared at the 8/1 (+/À) charge ratio, higher levels of gene expression were obtained when compared to 16/1 (+/À) Tf-lipoplexes. Association of DNA to cationic lipid, due to electrostatic interactions, leads to a reduction of the net positive charge of liposomes. This partial neutralization of the surface positive charges promotes particle aggregation, which results in lipid structures of larger size. 56 Although the existence of such changes may explain the higher in vitro transfection efficiency of the 2/1 and 4/1 (+/À) Tf-lipoplexes, 38 for which the high sedimentation capability overcomes the decrease in electrostatic interactions with the plasma membrane, the same is not true for in vivo gene transfer. The need for high lipid and DNA concentrations, in order to prepare a small volume of lipoplexes for stereotactic administration, favours the formation of very large aggregates, which may hamper diffusion through the brain parenchyma and cellular internalization by endocytosis. However, it is conceivable that for the higher lipid/DNA (+/À) charge ratios (8/1 and 16/ 1), the increasing repulsive forces among the particles may avoid, to some extent, the aggregation of complexes, thus facilitating their internalization. Another important aspect that should be considered is the degree of DNA condensation, which increases for higher lipid/DNA charge ratios. An extensive condensation of DNA may render difficult the dissociation of the lipoplexes, preventing the efficient intracellular delivery of the plasmid. This can explain the lower levels of transgene expression mediated by the 16/1 (+/À) Tf-lipoplexes as compared to the 8/1 (+/À) Tf-lipoplexes.
Our results indicate that, among the tested formulations, the 8/1 (+/À) Tf-lipoplexes exhibit the most adequate properties to promote lipoplex-mediated transgene expression in the rat striatum, and that optimization of the cationic lipid/DNA charge ratio is crucial when delivering a reporter or therapeutic gene. The studies employing the b-gal reporter gene also support the feasibility of CNS delivery of a therapeutic proteinencoding gene, using a nonviral delivery system. In the present study, the cationic liposomes composed of DOTAP:Chol were also used for transferring the NGF gene to the rat striatum, by means of a single stereotactic injection, in both a nonlesioned and lesioned animal model.
Although the benefits of administering exogenous neurotrophic factors for neuronal recovery are well known, 7, 8, 57 the limitations imposed by protein degradation and inefficient systemic delivery make nonviral delivery systems more favourable for in situ expression. Although it is accepted that gene delivery by nonviral vectors has little safety risks, their frequently observed low transfection efficiency constitutes a major concern. Nevertheless, if we consider that NGF is such a potent molecule that a low transgene expression, and/or a small number of transfected cells, is sufficient to drive significant biological effects, 58, 59 the transfection efficiency issue will be of minor significance.
Immunohistochemical assays were performed in order to evaluate the level of 8/1 (+/À) Tf-lipoplex-mediated NGF expression. Similar to the b-gal expression, a widespread NGF distribution was observed in a fairly consistent pattern across several sections (B1300 mm), thus confirming the ability of these lipoplexes to reach and be internalized by cells distant from the injection site. When testing the extent of NGF expression, this was observed to be transient, consistent with the fact that the plasmid, after being internalized, remains episomal. This time dependence of gene expression can represent a limitation if sustained protein production is required. However, under conditions where continuous protein accumulation may prove to be adverse, Tf-lipoplexes can represent a safe and clinically useful strategy, namely for neuroprotection.
As an approach to evaluate the capacity of Tflipoplexes to mediate neuroprotection and repair upon delivery of a therapeutic gene, we used a well-established excitotoxic lesion model by injecting a small amount of kainic acid into the rat striatum. Kainic acid is known to cause an increase in the levels of extracellular glutamate, [47] [48] [49] and the excitotoxicity of this amino acid is commonly related to the neuronal death observed for both neurodegenerative disorders and acute brain injuries. 45, 46 Owing to its neuroprotective effects, biologically delivered NGF has been reported to counteract the death of striatal neurons, caused by excitotoxic insults. [60] [61] [62] In this work, we investigated the potential of Tf-lipoplexes (prepared at the 8/1 (+/À) lipid/DNA charge ratio) to mediate both neuronal protection and regeneration upon delivery of the NGF gene. This strategy resulted in an impressive 75% reduction of the lesion volume, as assessed by TTC staining, 48 h after the kainic acid administration, independently of whether NGF transfection took place 24 h before or immediately after the lesion. Moreover, at 7 days following transfection, no visible lesion was observed in the neuronal tissue. These findings indicate that NGF gene transfer mediated by Tf-lipoplexes has a neuroprotective and repairing effect in this animal model of brain injury.
However, it should be emphasized that several parameters need to be further evaluated and optimized in order to make best use of this strategy. These include the characterization of the transfected cells, the achievement of a more specific expression of the transgene and the evaluation of the long-term effects of this therapeutic approach in other brain injury models. In addition, due
Tf-lipoplex-mediated gene transfer to the injured rat CNS M Teresa Girão da Cruz et al to the invasive nature of direct intracerebral injection, it will be necessary to test the efficiency of these liposomal formulations when delivered by other routes, especially to optimize their performance when administered intravenously. Nonetheless, to our knowledge, this is the first study reporting the potential of Tf-lipoplex gene transfer system to deliver therapeutic genes into the CNS, and to protect from an excitotoxic brain injury, in a safe and efficient manner.
Materials and methods
Animals
A total of 160 male Wistar rats, ranging in weight from 180 and 260 g, were used throughout this study (Charles River Laboratories, Barcelona, Spain). They were provided with a standard diet. All efforts were made to minimize the number of animals used and their suffer- 
Preparation of cationic liposomes and lipoplexes
The lipid DOTAP was purchased from Avanti Polar Lipids (Alabaster, AL, USA). Chol was purchased from Sigma (St Louis, MO, USA). Liposomes containing DOTAP:Chol at a 1:1 mol ratio were prepared by mixing the lipids and drying them from chloroform solution under vacuum using a rotatory evaporator. The dried lipid film was hydrated in a 5% dextrose aqueous solution and sonicated for 5 min. The resulting liposomes were then extruded 21 times through two stacked polycarbonate membranes (50 nm pore diameter) and diluted in 5% dextrose solution to a final DOTAP concentration of 60 mM. The suspension was stored at 41C, under nitrogen, until use. Chol concentration was measured with Sigma Diagnostics s Cholesterol Reagent (Sigma). Plain lipoplexes were prepared by sequentially mixing 5 mg of plasmid to a predetermined volume of liposomes in order to obtain the desired lipid/DNA (+/À) charge ratio. The mixture was incubated for 15 min at room temperature before use. The Tf-lipoplexes were obtained by mixing 6 ml of human Tf solution (Sigma) to a predetermined volume of liposomes, 15 min prior to the addition of 5 mg of plasmid DNA, and the resulting mixture was further incubated for 15 min. The Tf solution was prepared at 80 mg/ml in a 5% dextrose solution. Lipoplexes were used immediately after being prepared.
Stereotactic injection of lipoplexes
For intrastriatal injections, animals were anaesthetized with sodium thiopental (Abbot, IL, USA) (50 mg/kg, i.p.) and placed on a stereotactic apparatus with the nose positioned at 0.0. A midline incision was made, the soft tissues were reflected, and a burr hole was made in the skull, with the aid of a 25-gauge needle connected to an insulin syringe, at a point 0.5 mm anterior from bregma and lateral from the midline (sagital suture), according to Paxinos and Watson. 63 Plain lipoplexes or Tf-lipoplexes were injected at a rate of 0.2 ml/30 s via a 30-gauge stainless steel needle connected to a Hamilton syringe (Hamilton Bonaduz, Bonaduz, GR, Switzerland), 5.0 mm ventral from dura. At 3 min after the injection was completed, the needle was withdrawn and the skin was suturated. No specific symptoms, including loss of activity, were seen in any of the rats after administration of the lipoplexes.
Fixation and sectioning
Rats were killed at different times after transfection. Animals were deeply anaesthetized with an overdose of sodium thiopental (100 mg/kg), and transcardially perfused with 150 ml of an ice-cold solution of 0.9% NaCl and 10 mM heparin, followed by 150 ml of ice-cold 4% paraformaldehyde in 0.9% NaCl solution. The brains were removed and postfixed (12 h) in the same fixative solution, followed by 2-3 days cryoprotection in 30% sucrose solution in 0.9% NaCl. They were rapidly frozen in powdered dry ice, dipped in Tissue-Tek s OCT embedding medium (Sakura Finetek Europe, Mijdrecht, The Netherlands), and sections (30 mm) were cut, 1000 mm anterior and 1000 mm posterior to the injection site, at À201C in a cryostat (Shandon, AS620, Thermo Electron Corporation, Waltham, MA, USA) and stored at 41C in phosphate-buffered saline (PBS) containing 120 mM sodium azide (Sigma).
Immunohistochemical analysis
To detect b-gal or NGF expression in the rat brain, freefloating sections were rinsed with 0.05 M Tris-buffered saline (TBS). They were then sequentially incubated with 1% Triton (3 Â 15 min), 10% FBS (30 min) and with monoclonal anti-b-gal antibody (1:5000, Molecular Probes) or monoclonal anti-NGF antibody (1:5000; Alomone Labs, Jerusalem, Israel) (2 days, 41C). After 30 min at room temperature, sections were washed in 1% Triton (3 Â 15 min), incubated for 1 h with a biotinylated secondary antibody (1:200, Amersham, Uppsala, Sweden), washed in 1% Triton (3 Â 15 min) and then incubated for 1 h with the streptavidin-alkaline phosphatase complex (1:200, Sigma). After washing three times in TBS, and one time in Tris-HCl pH 9.5, the histochemical localization of b-gal or NGF was visualized with 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) (Sigma) and nitrobluetetrazolium (NBT) (Sigma), 3.4 ml/ ml (from a 50 mg/ml stock solution in 100% dimethylformamide) and 4.5 ml/ml (from a 70 mg/ml stock solution in 70% dimethylformamide), respectively, in staining buffer (Tris-HCl 15.8 g/l, NaCl 5.84 g/l, MgCl 2 . 6H 2 O 10.16 g/l, pH 9.5). Incubation was stopped by washing the sections in deionized water, which were subsequently dried on gelatin-coated glass slides, dehydrated in graded ethanol and cleared in toluene. They
Tf-lipoplex-mediated gene transfer to the injured rat CNS M Teresa Girão da Cruz et al were then mounted with Entellan (Merck), coverslipped, examined under a light microscope (Leica DMIL, Leica Microsystems, Bannockburn, IL, USA) and photographed with a digital camera (Canon Powershot S-40, Canon, Tokyo, Japan). The slides were scanned with a 1200 dpi flatbed scanner (HP ScanJet 3400C, HewlettPackard, Palo Alto, CA, USA) and the images were cropped with Paint Shop Pro 7.00 (Jasc Software, Eden Prairie, MN, USA).
Neurotoxicity and neuroprotection studies
Rats were anaesthetized, placed on a stereotactic apparatus and unilaterally infused with Tf-lipoplexes, containing 5 mg of either pCMV-NGF or pSIN-PGK-nlslacZ-WHV. The coordinates used were 0.5 mm anterior from bregma, 3.5 mm lateral from midline and 5.0 mm ventral from dura. At 24 h after the first injection, each animal was subjected to a second surgical procedure, and infused with 0.05 mg of kainic acid (Sigma), in PBS, in a final volume of 2 ml, at the following coordinates: 0.5 mm anterior from bregma, 2.5 mm lateral from midline and 5.0 mm ventral from dura (experimental sets [2] and [2*]). In parallel experiments, rats were sequentially injected with kainic acid (0.05 mg) and Tf-lipoplexes containing either pCMV-NGF or pSIN-PGK-nls-lacZ-WHV (5 mg) at the coordinates mentioned above (experimental sets [3] and [3*]). Experimental set [1] assigns for the control experiments (a single injection of either Tflipoplexes or kainic acid). The animals were killed at different times after the injection, and histological or immunohistochemical evaluation was performed.
Histological evaluation
Cresyl violet staining. The animals were anaesthetized and perfused as described above. Postfixation, freezing and sectioning were also as described. The sections were dried on gelatine-coated glass slides, and stained for 10 min in a 0.5% cresyl violet solution (Sigma) in acetate buffer (20% v/v of 2.7% NaCH 3 CO 2 and 80% (v/v) of 1.2% acetic acid, pH 3.8-4.0) (Sigma). After rinsing two times in acetate buffer, sections were dehydrated in ethanol (two times) and cleared in xylene. They were then mounted with Entellan (Merck), coverslipped, examined under a light microscope (Leica DMIL) and photographed with a digital camera (Canon Powershot S-40). The images were cropped with Paint Shop Pro 7.00. Tissue was considered damaged when intensively stained pyknotic nuclei were present and only few healthy cells were visible.
TTC staining. Animals were anaesthetized as described and transcardially perfused with 150 ml of an ice-cold solution of 0.9% NaCl and 10 mM heparin. The brains were removed and three coronal 1.5 mm sections were cut, consisting mainly of the striatum, and the frontal and parietal cortex. Sections were immediately transferred to an ice-cold solution of 0.9% NaCl, kept for 10 min, and then to a 2% solution of 2,3,5-triphenyltetrazolium chloride (TTC) (Sigma) in PBS and incubated in this solution for 20 min at 371C, in the dark, followed by a further overnight incubation in 4% paraformaldehyde in 0.9% NaCl solution. In viable cells, TTC, usually colourless, is converted by the dehydrogenases to a water-insoluble red formazan pigment, which stains tissue dark red. The sections were scanned with a 1200 dpi flatbed scanner (HP ScanJet 3400C), on both anterior and posterior sides, and analysed using the NIH Image Program (4.0.2 version for Windows, Scion Corporation, Frederick, MD, USA). The nonlesioned (dark red) and lesioned (pale in colour) areas were determined, for each section, for both sides and both hemispheres. The corresponding volumes were determined by multiplying the areas by the section thickness. To correct for the possible effects of cerebral oedema and differential shrinkage resulting from tissue processing, the lesion volume, in each section, was calculated by subtracting the volume of the nonlesioned tissue, in the ipsilateral hemisphere, from the volume of the contralateral hemisphere, as previously described. 64 
